Back
Ryan Specialty Holdings Vs. Kymera Therapeutics Industry Stock Comparison
Buy
55
RYAN
Ryan Specialty Holdings
Last Price:
63.09
Seasonality Move:
0.89%
Buy
58
KYMR
Kymera Therapeutics
Last Price:
46.38
Seasonality Move:
17.96%
Buy
55
Ryan Specialty Holdings (RYAN)
is a Buy
Is Ryan Specialty Holdings a Buy, Sell or Hold?
- The current Ryan Specialty Holdings [RYAN] share price is $63.87. The Score for RYAN is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- RYAN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $46.19. The Score for KYMR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RYAN Stock Price Chart
What is Ryan Specialty Holdings's stock price today?
-
The Ryan Specialty Holdings share price today is $63.87
The current trend is moderately bearish and RYAN is experiencing buying pressure, which is a positive indicator for future bullish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $46.19
The current trend is moderately bearish and KYMR is experiencing slight selling pressure.
RYAN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.51 | Buy |
| Relative Strength Index (14 RSI): | 51.78 | Buy |
| Chaikin Money Flow: | 742885 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (64.17 - 65.13) | Sell |
| Bollinger Bands (100): | (52.68 - 62.78) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.16 | Buy |
| Relative Strength Index (14 RSI): | 53.14 | Buy |
| Chaikin Money Flow: | -53339 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.25 - 48.01) | Buy |
| Bollinger Bands (100): | (32.65 - 44.29) | Buy |
RYAN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.24 | Sell |
| 20-day SMA: | 64.55 | Sell |
| 50-day SMA: | 61.75 | Buy |
| 200-day SMA: | 52.48 | Buy |
| 8-day EMA: | 64.15 | Sell |
| 20-day EMA: | 64.04 | Sell |
| 50-day EMA: | 61.98 | Buy |
| 200-day EMA: | 54.59 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.97 | Sell |
| 20-day SMA: | 46.18 | Buy |
| 50-day SMA: | 42.65 | Buy |
| 200-day SMA: | 35.44 | Buy |
| 8-day EMA: | 46.57 | Sell |
| 20-day EMA: | 45.95 | Buy |
| 50-day EMA: | 43.11 | Buy |
| 200-day EMA: | 36.01 | Buy |
Ryan Specialty Holdings Earnings Growth & RYAN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.11 per share, an increase this year of $0.43 per share, and an increase next year of $0.41 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.51 per share.
Ryan Specialty Holdings Technical Analysis
| Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||